Shareholders Equity: The sum of preferred and common equity items.
bioMerieux (BMXMF) had Shareholders Equity of $4.65B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.87B |
|
-- |
|
$1.56B |
|
$6.31B |
|
$1.20B |
|
$373.36M |
|
$457.08M |
|
$1.66B |
|
$4.65B |
|
$3.37B |
|
|
Shareholders Equity |
$4.65B |
-- |
|
| Cash Flow Statement Financials | |
$891.88M |
|
$-522.37M |
|
$-175.82M |
|
$500.19M |
|
$639.35M |
|
$139.16M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|